基于微生物组的治疗方法的过去,现在和未来
Pilar Manrique1, Ignacio Montero1, Marta Fernandez-Gosende1
1Department of R&D, Microviable Theapeutics S.L., Gijón 33203, Spain.
Microbiome research reports
|June 6, 2024
概括
人的肠道微生物群在健康和疾病中起着关键作用,影响感染和癌症. 基于微生物组的疗法正在迅速发展,以调节肠道细菌以改善健康结果.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 技术进步允许对人类微生物组进行深入研究.
- 微生物签名与各种健康和疾病状态有关.
- 肠道微生物群对于维持宿主平衡至关重要.
研究的目的:
- 审查肠道微生物群对传染病和癌症的影响.
- 分析肠道微生物群和药物之间的双向相互作用.
- 探索微生物组调制策略及其监管框架.
主要方法:
- 基于微生物组的治疗方法的文献评论.
- 对宿主微生物群相互作用的分析.
- 探索当前和未来的调制策略.
主要成果:
- 肠道微生物群影响传染病和癌症的发展.
- 微生物群的组成会影响药物的疗效和治疗反应.
- 微生物组调制存在各种策略,从基本到高级.
结论:
- 基于微生物组的疗法显示出治疗癌症和感染等疾病的巨大潜力.
- 了解微生物群与药物相互作用是优化治疗结果的关键.
- 未来的疗法可能会利用人工智能进行个性化微生物组调节.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
01:50What is Monogastric Digestion?
71.1K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.1K